Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07002866 · ClinicalTrials.gov registry record · NA
Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda
A NA study of HIV Prevention, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 2
- Study locations
NCT07002866: Recruiting NA study of HIV Prevention, sponsored by Washington University School of Medicine.
NCT07002866 is a NA study of HIV Prevention that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 600 participants, above the 363-participant average among 32 other HIV Prevention trials with a reported enrollment target (65% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07002866, a NA study of HIV Prevention, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study will employ a multilevel combination intervention focused on PrEP initiation and adherence among adolescent girls and young women (AGYW) (aged 15-24) living in HIV hotpots in Uganda. Specifically, the study will combine: 1) HIV risk reduction (HIVRR) that incorporates sessions on PrEP, 2) Peer Supporters (PS) with lived experiences taking PrEP to facilitate linkage to and continued care, share strategies to address misconceptions, manage disclosure and stigma, and model positive lifestyles while engaging in care services, and 3) an economic empowerment (EE) component that includes a matched savings account and financial literacy targeting poverty and financial barriers associated with PrEP access. Working within 30 health care systems, we will randomly assign 600 AGYW (at the community level) to one of three study arms (n=200 AGYW, n=10 sites per arm): 1) HIVRR only, 2) HIVRR+ PS, or 3) HIVRR + PS + EE. The interventions will be implemented for 20 months, and data collected at baseline, 12, 24, 36 months.
Primary Outcome
Proportion of eligible participants who initiate PrEP
Conditions Studied
Interventions
- BEHAVIORAL HIV Risk Reduction (HIVRR)
- BEHAVIORAL PrEP Peer Supporters (PS)
- BEHAVIORAL Matched Savings Accounts + Financial Literacy (FL)
Study Locations (2)
Missouri
- Washington University in St. Louis - St Louis
Other
- International Center for Child Health and Development (ICHAD) - Masaka
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2025-10-20 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
What NCT07002866 shows while recruiting
NCT07002866 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 363-participant average among 32 other HIV Prevention trials with a reported enrollment target (65% higher).
The record links to 1 condition, with HIV Prevention appearing as the primary indexed condition, and to 3 interventions - of which HIV Risk Reduction (HIVRR) is the first listed.
NCT07002866 reports a single indexed study location in Missouri, Other.
Frequently Asked Questions
What is clinical trial NCT07002866 about?
NCT07002866 is a clinical study titled "Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda". The study will employ a multilevel combination intervention focused on PrEP initiation and adherence among adolescent girls and young women (AGYW) (aged 15-24) living in HIV hotpots in Uganda. Specifically, the study will combine: 1) HIV risk reduction (HIVRR) that incorporates sessions on PrEP, 2) ...
What is the current status of trial NCT07002866?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2025-10-20. Estimated completion is 2029-12-31.
What conditions does trial NCT07002866 study?
This clinical trial studies the following conditions: HIV Prevention.
What interventions are being tested in trial NCT07002866?
The interventions under investigation include: HIV Risk Reduction (HIVRR) (BEHAVIORAL), PrEP Peer Supporters (PS) (BEHAVIORAL), Matched Savings Accounts + Financial Literacy (FL) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07002866?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07002866 being conducted?
This trial has 2 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07002866's enrollment target sits among peer trials
600 4th of 32 higher than 29 of 32 other HIV Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Using PrEP, Doing It for Ourselves
RECRUITING · NA
-
Client-Centered Care Coordination for Black Men Who Have Sex With Men
RECRUITING · NA
-
Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
RECRUITING · NA
-
Intervention to Enhance PrEP Persistence
RECRUITING · NA
-
WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women
RECRUITING · NA
-
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI